Challenge:
A biotech developing a high-cost, one-time gene therapy lacked expertise to navigate payer models and reimbursement challenges.
What Efficus Health did:
Conducted payer research, developed a defensible pricing strategy, and built a roadmap for access and reimbursement. We also provided value-communication tools to equip the client’s leadership for payer engagement and investor discussions.
Outcome:
Provided a clear plan that de-risked market entry, secured payer engagement, and positioned the therapy for commercial success. This blueprint also reassured investors that the company had a viable path to revenue and patient access.
“Efficus Health’s in-depth payer research and strategy gave us a roadmap that de-risked both our market access and investment strategy.”
– VP, Market Access